GGrantIndex
Sort

23,748 grants matching melanoma

Administrative Core

$1,091,572
Raymond E Samuel · Hampton University · U54 · FY2014 · MD

Mutational analysis of signal transducing gene families in malignant melanoma

$1,091,545
Yardena Samuels · National Human Genome Research Institute · ZIA · FY2010 · HG

TARGETING AUTOPHAGY VIA THE MENIN PROTEIN TO INHIBIT MELANOMA METASTASIS

$1,091,290
University Of Miami · · FY2021 · Defense Health Agency

Directing Tumor-specific T cells to Tumors

$1,091,197
Pawel Kalinski · University Of Pittsburgh At Pittsburgh · P01 · FY2009 · CA

GWAS HumanOmniExpress Plus Exome for NCI

$1,091,160
Johns Hopkins University · N01 · FY2012 · CA

Collaborative Protein Technology Resource - Nano-Scale Protein Analysis Section

$1,090,698
Noemi Kedei · Division Of Basic Sciences - Nci · ZIC · FY2022 · CA

NHGRI/DIR Cytogenetics and Microscopy Core

$1,090,671
Leslie Biesecker · National Human Genome Research Institute · ZIC · FY2010 · HG

High-throughput sequencing to identify novel melanoma susceptibility genes

$1,090,017
Chad Daniel Huff · University Of Tx Md Anderson Can Ctr · R01 · FY2015 · CA

Integrated analyses of genetics, epigenetics, and gene expression

$1,089,132
Maxwell Lee · Division Of Basic Sciences - Nci · ZIH · FY2020 · CA

Role of Neurotrophins and Their Receptors in the Development of the Mammalian Ne

$1,086,465
Lino Tessarollo · Basic Sciences · Z01 · FY2007 · CA

Infections, immunity, and inflammation in cancer

$1,085,068
Eric A Engels · Division Of Cancer Epidemiology And Genetics · ZIA · FY2015 · CA

Genetically Engineered Mouse Models to Study RTK Function in Melanoma

$1,084,624
Glenn T. Merlino · Division Of Basic Sciences - Nci · ZIA · FY2016 · CA

Prevention of AIDS

$1,083,056
Barbara Felber · Division Of Basic Sciences - Nci · ZIA · FY2018 · CA

Function genomic analysis of neural crest development

$1,082,555
William J Pavan · National Human Genome Research Institute · ZIA · FY2010 · HG

Genetically Engineered Mouse Models to Study RTK Function in Melanoma

$1,082,439
Glenn T. Merlino · Division Of Basic Sciences - Nci · ZIA · FY2011 · CA

Molecular And Immunopathology Of Experimental And Clinical Ocular Diseases

$1,081,049
Chi-Chao Chan · National Eye Institute · ZIA · FY2009 · EY

Immune Escape in Human Cancer: Mechanisms and Therapeutic Implications

$1,081,004
Theresa L. Whiteside · University Of Pittsburgh At Pittsburgh · P01 · FY2007 · CA

POLYVALENT VACCINE--PHASE III TRIAL IN STAGE IV MELANOMA

$1,080,112
John Wayne Cancer Institute · R01 · FY2001 · CA

DCTD Screening Technologies

$1,080,000
Larry Arthur · Leidos Biomedical Research, Inc. · N01 · FY2010 · CA

Developing Novel Therapies for High Risk Pediatric Cancers

$1,079,318
Javed Khan · Division Of Basic Sciences - Nci · ZIA · FY2025 · CA

UT M.D. Anderson Cancer Center SPORE in Melanoma

$1,079,303
Elizabeth A Grimm · University Of Tx Md Anderson Can Ctr · P50 · FY2009 · CA

Vaccines and Therapeutics for Anthrax

$1,079,233
Stephen H Leppla · National Institute Of Allergy And Infectious Diseases · Z01 · FY2008 · AI

GERMLINE GENETIC DETERMINANTS OF TRANSFORMATION OF UVEAL NEVI TO MELANOMA: TOWARDS EARLY DIAGNOSIS AND PREVENTION OF DISEASE PROGRESSION

$1,078,337
Ohio State University, The · · FY2021 · Defense Health Agency

Genomic Sunlight Dosimeters for Melanoma Prevention

$1,077,491
Douglas E Brash · Yale University · P50 · FY2012 · CA

Genetic and molecular basis for variation in human skin pigmentation

$1,076,923
Michael S Marks · Children'S Hosp Of Philadelphia · R01 · FY2024 · AR